Bart Leten
Universiteit Hasselt
H-index: 21
Europe-Belgium
Top articles of Bart Leten
Title | Journal | Author(s) | Publication Date |
|---|---|---|---|
EXPRESS: The Long March: The Quest for Valid Text-Based Indicators of Exploration and Exploitation | Strategic Organization | Nazlihan Ugur Rene Belderbos Stijn Kelchtermans Bart Leten | 2024/1/31 |
The Long March: The Quest for Valid Text-Based Indicators of Exploration and Exploitation | Strategic Organization | Nazlihan Ugur Rene Belderbos Stijn Kelchtermans Bart Leten | 2024/1/22 |
Many are called, few are chosen: the role of science in drug development decisions | The Journal of Technology Transfer | Linde Colen René Belderbos Stijn Kelchtermans Bart Leten | 2023/3/13 |
Offshoring and Mental Health: Towards an Employee Perspective | Christoph Grimpe Robin John Clerckx Bart Leten Mark Vancauteren | 2023 | |
International R&D and MNCs' innovation performance: An integrated approach | Journal of International Management | René Belderbos Bart Leten Shinya Suzuki | 2023/12/1 |
Multinational firms and the quest for global talent: Employing (skilled) foreign workers at home and abroad | Journal of International Business Studies | René Belderbos Bart Leten Ngoc Hân Nguyen Mark Vancauteren | 2023/8/16 |
Does constructive feedback improve idea quality in idea contests? Exploring the role of hierarchy and feedback overlap | R&D Management | Mathias Boënne Bart Leten Walter Van Dyck | 2023/6 |
Top Management Team Internationalization and Innovation: The Role of International R&D Collaboration | Academy of Management Proceedings | Eline Wijns Rene Belderbos Bart Leten Boris Lokshin Mark Vancauteren | 2022 |
Acquisitions Among VC-Backed Entrepreneurial Ventures: Venture Capitalists As Intermediaries | Academy of Management Proceedings | Hamzeh Obeid Bart Leten | 2022 |
Do licensors learn from out-licensing? Empirical evidence from the pharmaceutical industry | Technovation | Stijn Kelchtermans Bart Leten Maarten Rabijns Massimo Riccaboni | 2022/4/1 |
How does basic research improve innovation performance in the world’s major pharmaceutical firms? | Industry and Innovation | Bart Leten Stijn Kelchtermans Rene Belderbos | 2022/3/16 |
Reaching for the stars: When does basic research collaboration between firms and academic star scientists benefit firm invention performance? | Journal of Product Innovation Management | Linde Colen René Belderbos Stijn Kelchtermans Bart Leten | 2022/3 |
Whither geographic proximity? Bypassing local R&D units in foreign university collaboration | Journal of international business studies | Rene Belderbos Marcelina Grabowska Stijn Kelchtermans Bart Leten Jojo Jacob | 2021/9 |
Designing idea contests to optimize the front end of the innovation process. | Mathias Boënne | 2021/4/29 | |
The Role of Science in Drug Development Decisions | Academy of Management Proceedings | Linde Colen Rene Belderbos Stijn Kelchtermans Bart Leten | 2021 |
Essays on innovation in multinational enterprises: R&D organization, knowledge transfer and global mindset. | Marcelina Grabowska | 2020 | |
Mounting corporate innovation performance: The effects of high-skilled migrant hires and integration capacity | Research Policy | Keld Laursen Bart Leten Ngoc Han Nguyen Mark Vancauteren | 2020/11/1 |
How valuable are patent blocking strategies? | Review of Industrial Organization | Dirk Czarnitzki Katrin Hussinger Bart Leten | 2020/5 |
Multistep knowledge transfer in multinational corporation networks: when do subsidiaries benefit from unconnected sister alliances? | Journal of Management | Dries Faems Brenda Bos Florian Noseleit Bart Leten | 2020/3 |
Temporal dynamics in multipartner coordination: Sequentiality and simultaneity in multipartner R&D collaboration | Jingshu Du Rene Belderbos Bart Leten | 2020/1/1 |
Co-Authors
